Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses

Heart

Volumn 89, Issue 7, 2003, Pages 715-721

  Oxenham, H ^a   Bloomfield, Peter ^a   Wheatley, D J ^a,c   Lee, R J ^b   Cunningham, J ^a   Prescott, R J ^b   Miller, H C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIAL ENDOCARDITIS; BIOPROSTHESIS; BJOERK SHILEY VALVE PROSTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DEATH; EMBOLISM; FOLLOW UP; HEART ASSIST DEVICE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MITRAL VALVE DISEASE; MITRAL VALVE REPLACEMENT; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; REOPERATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0038207177     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.7.715     Document Type: Article

References (19)

1. Bloomfield P, Kitchin AH, Wheatley DJ, et al. A prospective evaluation of the Bjork-Shiley, Hancock and Carpentier-Edwards heart valve prostheses. Circulation 1986;73:1213-22.
2. Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573-9.
3. Magilligan DJ, Lewis JW, Tilley B, et al. The porcine bioprosthetic valve: twelve years later. J Thorac Cardiovasc Surg 1985;89:499-507.
4. Foster AH, Greenberg GJ, Underhill DJ, et al. Intrinsic failure of Hancock mitral bioprosthesis: 10 to 15 year experience. Ann Thorac Surg 1987;44:568-77.
5. Akins CW, Carroll DL, Buckley MJ, et al. Late results with Carpentier-Edwards porcine bioprosthesis. Circulation 1990;82(suppl IV):IV-65-74.
6. Bolooki H, Mallon S, Kaiser GA, et al. Failure of Hancock xenograft valve: importance of valve position (4- to 9-year follow up). Ann Thorac Surg 1983;36:246-52.
7. Magilligan DJ, Kemp SR, Stein PD, et al. Asynchronous primary valve failure in patients with porcine bioprosthetic aortic and mitral valves. Circulation 1987;76(suppl III):III-141-5.
8. UK Heart Valve Registry. The United Kingdom Heart Valve Registry report, 1997. London: United Kingdom Heart Valve Registry, Imperial College School of Medicine, Hammersmith Hospital, 1999.
9. Akins CW, Buckley MJ, Daggett WM, et al. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg 1998;65:1545-52.
10. Poller L. Therapeutic ranges in anticoagulant administration. BMJ 1985;290:1683-6.
11. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.
12. Acar J, Iung B, Boissel JP, et al, and the AREVA Group. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-12.
13. Hammermeister KE, Henderson WG, Burchfiel CM, et al. Comparison of outcome after valve replacement with a bioprosthesis versus a mechanical prosthesis: initial 5 year results of a randomised trial. J Am Coll Cardiol 1987;10:719-32.
14. Hammermeister KE, Sethi GK, Henderson WG, et al. A comparison of outcomes in men 11 years after heart valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 1993;328:1289-96.
15. Hammermeister KE, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomised trial. J Am Coll Cardiol 2000;36:1152-8.
16. Hirsh J. Is the dose of warfarin prescribed by American physicians unnecessarily high? Arch Intern Med 1987;147:769-71.
17. Grover FL, Cohen DJ, Oprian C, et al. Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg 1994;108:208-14.
18. Peterseim DS, Cen Ye-Ying, Cheruvu S, et al. Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg 1999;117:890-7.
19. Nitter-Hauge S. Mechanical heart valves. Conclusions from long-term follow up. Eur Heart J 1997;18:907-10.